This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Kee Song Bio-Technology Holdings Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Kevin Tan
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 12.3yrs |
CEO
Kevin Tan
less than a year
Tenure
Kevin Tan is General Manager of Kee Song Bio-Technology Holdings Limited from August 19, 2022. Kevin Tan is a COO of Kee Song Group.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 12.3yrs | NT$749.00k | no data | |
| Chairman | 13.1yrs | no data | no data | |
| Independent Director | 12.3yrs | NT$642.00k | no data | |
| Director | 1.4yrs | no data | no data | |
| Independent Director | 1.4yrs | no data | no data | |
| Independent Director | no data | NT$669.00k | no data |
12.3yrs
Average Tenure
Experienced Board: 1258's board of directors are seasoned and experienced ( 12.3 years average tenure).